PHRMA

The same issues that affect PhRMA in the United States also have implications abroad for PhRMA International. This page contains resources found on PhRMA’s Web sites as well as third party sites. Issues covered range from medical and pharmaceutical intellectual property (IP), prescription assistance programs, counterfeit drugs, drug safety and other issues affecting the International pharma community.

Latest news and updates:

Comments filed by PhRMA to the White House Intellectual Property Enforcement Coordinator, March 24, 2010

PhRMA Special 301 Submission 2010

PhRMA Special 301 Testimony

Report: Brazil able to Compete in Medical Innovation

Drug Innovation | Brazil is able to compete in medical innovation, report says (translation) | (original article)

Thwarting Counterfeiters Keeps U.S. Competitive

Safeguarding Against Substandard, Counterfeit drugs